Cargando…
Cardiac fibroblast activation in Fabry disease on (18)F-fibroblast activation protein inhibitor positron emission tomography/computed tomography imaging
Autores principales: | Wang, Yi-Lu, Wang, Li, Dong, Zhixiang, Yang, Min-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631965/ https://www.ncbi.nlm.nih.gov/pubmed/36339458 http://dx.doi.org/10.1093/ehjcr/ytac419 |
Ejemplares similares
-
Severe myocardial ischemia detected in routine oncological positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose
por: Freitag, Martin T, et al.
Publicado: (2023) -
Cardiac fibroblast activation detected by (68)Gallium-FAPI-46 positron emission tomography–magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosis
por: Siebermair, Johannes, et al.
Publicado: (2022) -
Somatostatin receptor positron emission tomography/computed tomography in myocarditis following mRNA COVID-19 vaccination
por: Bollano, Entela, et al.
Publicado: (2022) -
One stop non-invasive imaging of coronary artery bypass graft occlusion and ischaemia with combined (82)Rubidium positron emission tomography/coronary computed tomography
por: Strobel, Klaus, et al.
Publicado: (2023) -
A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease
por: Lyu, Zhehao, et al.
Publicado: (2022)